Dinaciclib in Treating Patients With Stage IV Melanoma
Status:
Active, not recruiting
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This phase II trial is studying the side effects and how well dinaciclib works in treating
patients with stage IV melanoma. Dinaciclib may stop the growth of tumor cells by blocking
some of the enzymes needed for cell growth.